Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
About this role
AstraZeneca is offering a master's thesis position focused on developing in vitro models of mitochondrial dysfunction in acute kidney injury using human renal cells. The role provides hands-on experience with advanced cell culture and analytical techniques, contributing to research aimed at understanding and treating kidney diseases.
Skills
Qualifications
About AstraZeneca
astrazeneca.comDigital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
About AstraZeneca
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AstraZeneca.
More jobs at AstraZeneca
Similar Jobs
Principal Scientist, Kidney Disease Research Expert - In Vitro, CVRI
City of Duncan, Oklahoma
Postdoctoral Scientist – Mitochondrial Biology
University of Pennsylvania
Scientist II, In Vitro Pharmacology
AbbVie
Scientist II, Complex In Vitro Models
AbbVie
Associate Scientist II, In Vitro Pharmacology
AbbVie
Associate Scientist II, In Vitro Pharmacology
AbbVie